Markets |
Wall Street rally fizzles out as oil, materials fall
DJ: 17,502.59 -79.98 NAS: 4,768.86
-52.80 S&P: 2,036.71
-13.09
(Reuters) Wall
Street closed lower on Wednesday as oil and materials share prices dropped
while investors remained cautious a day after deadly bombing attacks in
Belgium. The benchmark S&P 500 index fell
back into negative territory for the year after closing positive on Friday for
the first time in 2016.
U.S. stocks' fading five-week rally was further diminished by
comments over the past two days by Federal Reserve officials, who expressed views that suggested an
appetite for more U.S.
interest rate hikes than investors had anticipated.
The possibility
of more than the two expected rate hikes through December has sent the
dollar higher .DXY, pushing down commodity prices .TRJCRB.
"That's basically what's leaning on the market today," said Peter
Cardillo, Chief Market Economist at First Standard Financial in New York.
"It's all about commodities."
Gold XAU= and metals CMCU3 prices fell as the dollar
strengthened.
U.S. oil prices CLc1 LCOc1 also were also damaged after data
showing a rise in U.S. stockpiles last week rekindled worries about a global
glut.
Eight of the 10 major S&P sectors were lower, led by a
2.1-percent fall in the energy sector .SPNY. Chevron (CVX.N) and
ConocoPhillips (COP.N) were
among the biggest decliners. Utilities .SPLRCU rose 0.7 percent and was the
best performing sector.
The Dow Jones industrial
average .DJI closed down 79.98 points, or 0.45
percent, to 17,502.59, the S&P 500 .SPX lost 13.09 points, or 0.64 percent, to
2,036.71 and the Nasdaq Composite .IXIC fell 52.80 points, or 1.1 percent, to
4,768.86.
Adding to the downturn, investors were deterred by the shortened
trading week ahead of the Good Friday holiday and uncertainty tied to Tuesday's
bombings in Brussels, Cardillo said.
Earnings weakness has been another concern for investors, with
first-quarter S&P 500 earnings forecast to fall 6.9 percent from a year
ago, according to Thomson Reuters data.
Nike (NKE.N)
shares were down 3.8 percent at $62.44 after the world's largest footwear maker
reported quarterly revenue below estimates.
Gilead Sciences (GILD.O) was
down 3.9 percent at $90.08 while Merck (MRK.N) was
up 0.09 percent. A federal jury upheld the validity of two Merck patents in a
high-profile dispute over Gilead's blockbuster cure for hepatitis C.
Gilead was the biggest drag on the S&P 500 and the Nasdaq.
Vertex Pharmaceuticals (VRTX.O) fell
7.6 percent to $80.15 after Goldman Sachs cuts its price target on the stock.
Yum Brands (YUM.N) was
up 2 percent at $80.55 after the Wall Street Journal reported that the
fast-food chain's owner was in talks with KKR (KKR.N) about
a possible sale of a 19.9-percent stake in its China business.
Volume was lighter than
in recent sessions. About 6.8 billion shares changed hands on U.S.
exchanges, compared with the 8.1 billion daily average for the past 20 trading
days.
Declining issues outnumbered advancing ones on the NYSE by 2,257
to 771, for a 2.93-to-1 ratio on the downside; on the Nasdaq, 2,221 issues fell
and 579 advanced for a 3.84-to-1 ratio favoring decliners.
The S&P 500 posted 17 new 52-week highs and no new lows; the
Nasdaq recorded 21 new highs and 40 new lows.
No comments:
Post a Comment